AzTrials
AzTrials

MisophoniaPROMISENCT06921187

Study of Auditory Perception After Progressive Exposure to Aversive Sounds in People With Misophonia

A study testing Psychoacoustic test, semi-structured interviews and Exposure to unpleasant sounds in people with Misophonia, run by Institut Pasteur at 2 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objective of the project is to characterise and measure the auditory perception of subjects with misophonia compared with the auditory perception of control subjects. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Misophonia
What is being tested?
Psychoacoustic test, semi-structured interviews and Exposure to unpleasant sounds
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
2 sitesFrance
Study dates
Jun 2025to Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For all participants
  • Obtain oral consent from the participant after receiving information about the study,
  • Be 18 years or older on the day of inclusion,
  • Be fluent in French (spoken and written),
  • Have no known hearing loss, verified by pure tone audiometry.
  • Declare that they do not have tinnitus,
Show all 10Show fewer
  • Declare that they do not have hyperacusis, verified by measuring discomfort thresholds.
  • Be affiliated to the social security or equivalent scheme.
  • For participants with misophonia:
  • Declare discomfort, reduced tolerance to specific sounds (mouth noises, throat clearing, breathing, etc.).

Who cannot join

  • Bear the after-effects of an ear infection and/or have a history of an ENT disease that permanently affects hearing or balance (vestibular schwannoma, Ménière's disease, sudden or fluctuating deafness, congenital hypoacusis),
  • Be under guardianship,
  • deprived of liberty by judicial or administrative decision, or subject to legal protection.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Paul Avan contact

paul.avan@pasteur.fr

France2 sites
  • Centre de Recherche en Psychologie et Neuroscience (CRPN)

    Marseille, 13003

    Arnaud Norena, +33488576863, arnaud.norena@univ-amu.fr

  • CEntre de Recherche et d'Innovation en Audiologie Humaine

    Paris, 75015

    Paul Avan, +331 76 53 50 93, paul.avan@pasteur.fr

Other trials in France

About this study

Official title: Etude de la Perception Auditive après Exposition PROgressive Aux Sons Aversifs Chez Des Personnes MISophonEs

The primary objective of the project is to characterise and measure the auditory perception of subjects with misophonia compared with the auditory perception of control subjects.

Conditions
Misophonia
Being tested
Psychoacoustic test, semi-structured interviews, Exposure to unpleasant sounds
Medical subject headings
misophonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychoacoustic testBehavioural

    Natural sounds will be presented at different decibels (dB), and the subject will be asked to rate the pleasantness/unpleasantness of the sound heard on a visual analogue scale, as well as the loudness (subjective intensity) of the sound heard.

  • semi-structured interviewsOther

    interview, designed under the supervision of a psychologist and using the methodology of micro-phenomenological interviews the aim of these interviews is to gain access to the participants' experiences, as they describe them in the first person, during misophonic episodes

  • Exposure to unpleasant soundsOther

    Home exposure is a practice whereby participants voluntarily subject themselves to SMs in a controlled environment.

    Participants will be asked to complete two tasks: firstly, they will have to expose themselves to all 10 sounds at least twice a week; secondly, they will have to record the annoyance felt for each sound and the subjective loudness (loudness) of each SM using VAS.

Study groups in NCT06921187
Study groupRoleWhat they receive
Control groupActive comparatorNot described
Receives: Behavioral: Psychoacoustic test; Other: semi-structured interviews
Misophonia groupExperimentalNot described
Receives: Behavioral: Psychoacoustic test; Other: semi-structured interviews; Other: Exposure to unpleasant sounds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. score on a visual analogue scale from 0 (pleasant sound) to 10 (unpleasant sound)

    sounds will be presented at different decibels and the subject will be asked to rate the pleasantness/unpleasantness of the sound on a visual analogue scale

    Measured: 1 week after enrollment

  2. score on a visual analogue scale from 0 (very low intensity) to 10 (extremely intense)

    sounds will be presented at different decibels and the subject will be asked to rate the intensity of the sound on a visual analogue scale

    Measured: 1 week after enrollment

Secondary outcomes (3)
  1. Measuring the consistency of the psychoacoustic test

    consistency measured by calculating Cronbach's alpha coefficient

    Measured: 1 week after enrollement

  2. the number of redundant themes in the semi-structured interviews

    the interviews consist of open-ended questions covering different aspects of the experiences of misophone subjects

    Measured: 1 month after enrollment

  3. score on a visual analogue scale from 0 (very little discomfort) to 10 (extreme discomfort)

    Measured: 1 month after enrollment and 2 months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2025
  2. Study startJun 2025 (estimated)
  3. Primary completionMar 2026 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
exposure to unpleasant sounds at home is the focus of this study
Masking
None (open label)
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06921187
Sponsor's protocol ID
2024-058
Other IDs
2024-A02048-39
Acronym
PROMISE
Status last verified
Mar 2025
First submitted
18 Mar 2025
Last updated
10 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Psychoacoustic test, semi-structured interviews and Exposure to unpleasant sounds in people with Misophonia, run by Institut Pasteur at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Arnaud Norena (+33488576863, arnaud.norena@univ-amu.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

score on a visual analogue scale from 0 (pleasant sound) to 10 (unpleasant sound) (time frame: 1 week after enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in